MAP3K3 and nasopharyngeal carcinoma: To investigate whether MAP3K3 knockdown could interfere the proliferation of nasopharyngeal carcinoma cells in vitro, cell number and MTT assays were performed to evaluate CNE‐1 and C666‐1 cells transfected with shRNAs targeting MAP3K3.